Metabolic Studies of Adrenoleukodystrophy
Two series of metabolic studies were prompted by the previous finding that the brain and adrenal tissues of patients with adrenoleukodystrophy, an X-linked genetic disorder,contain unusually long-chain (C22 – C32) fatty acids in cholesterol esters and gangliosides. Postmortem brain tissues from three patients were assayed for activities of the three distinct cholesterol ester hydrolases, using [4-14C]cholesterol oleate, lignocerate and cerotate as the substrates. No deficiency of the crude mitochondrial (pH 4.2), the microsomal (pH 6.0), or the myelin-localized cholesterol ester hydrolases was detected, although the activities of the myelin-localized cholesterol ester hydrolase against cholesteryl lignocerate and cerotate were too low for reliable assays. The activities of the microsomal and myelin-localized hydrolases were actually higher in adrenoleukodystrophy than in controls. Upt le and exclusion by cultured fibroblasts of [1-14C]stearic, [1- C]lignoceric and [1-14C]cerotic acids were also examined. All fatty acids were avidly taken up by the fibroblasts. Stearic acid was excluded from the cells much more rapidly than lignoceric or cerotic acid. No difference was observed in the uptake and exclusion of fatty acids between the controls and adrenoleukodystrophy, except that cells from some cases of adrenoleukodystrophy consistently took up the very long chain fatty acids at greater rates than the control cells. Neither did the distribution of the label among individual lipids reveal differences between the controls and adrenoleukodystrophy, although there were interesting and dramatic differences in the metabolism of lignoceric acid and cerotic acid. Cerotic acid appeared largely inert with 90–95% remaining intact over eight days, while lignoceric acid was mostly incorporated into complex lipids. This series of studies did not uncover the fundamental genetic defect underlying adrenoleukodystrophy.
KeywordsStearic Acid Cholesteryl Ester Cholesterol Ester Control Cell Line Cholesteryl Ester Hydrolase
Unable to display preview. Download preview PDF.
- 1.Barron, K.D., Bernsohn, J. and Koeppen, A., Esterases of human CNS and PNS and myelin fractions, J. Histochem. Cytochem. 18 (1970) 683.Google Scholar
- 4.Burton, B.K. and Nadler, H.L., Schilder’s disease: Abnormal cholesterol retention and accumulation in cultivated fibroblasts, Pediat. Res. 8 (1974) 170–175.Google Scholar
- 5.Eto, Y. and Suzuki, K., Cholesterol ester metabolism in the brain: Properties and subcellular distribution of cholesterol esterifying enzyme and cholesterol ester hydrolases in adult rat brain, Biochim. Biophys. Acta 239 (1971) 293–311.Google Scholar
- 17.Lowry, 0.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J., Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193 (1951) 265–275.Google Scholar
- 18.Miller, G.L., Protein determination for large numbers of samples, Analyt. Chem. 31 (1959) 964.Google Scholar
- 23.Suzuki, K., Biochemistry of myelin disorders, in the Physiology and Pathology of Axons (Waxman, S.G., ed.), Plenum Press, New York (1977) in press.Google Scholar
- 24.Yavin, E., Milunsky, A., DeLong, G.R., Nash, A.H. and Kolodny, E.H., Cholesterol metabolism in cultured fibroblasts in adrenoleukodystrophy, Pediat. Res. 10 (1976) 540–543.Google Scholar